US Stock MarketDetailed Quotes

Medpace (MEDP)

Watchlist
  • 520.600
  • +4.950+0.96%
Close Apr 17 16:00 ET
  • 520.600
  • 0.0000.00%
Post 20:01 ET
14.87BMarket Cap34.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Medpace (MEDP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.15%713.22M
1.04%192.65M
65.16%246.21M
27.60%148.53M
-17.58%125.84M
40.48%608.82M
21.91%190.67M
30.33%149.08M
41.06%116.4M
90.67%152.68M
Net income from continuing operations
11.56%451.12M
15.48%135.13M
15.25%111.14M
2.16%90.26M
11.70%114.6M
42.99%404.39M
49.45%117.02M
36.68%96.43M
44.68%88.35M
40.74%102.59M
Depreciation and amortization
-3.85%28.12M
-5.00%7.13M
-6.24%7.05M
-3.05%7.01M
-0.89%6.93M
11.10%29.25M
7.66%7.51M
9.31%7.52M
10.97%7.24M
17.35%6.99M
Deferred tax
403.29%80.77M
171.93%17.41M
1,983.09%28.51M
63,261.11%34.11M
186.59%749K
-6.03%-26.63M
-75.24%-24.2M
80.08%-1.51M
97.96%-54K
18.63%-865K
Other non cash items
15.82%22.14M
-7.14%5.24M
-3.08%5.73M
-7.99%5.61M
279.40%5.56M
-14.48%19.12M
-18.77%5.65M
-10.98%5.91M
11.62%6.09M
-55.60%1.47M
Change In working capital
-38.75%96.28M
-71.93%22.12M
201.52%87.46M
-50.03%5.59M
-149.48%-18.89M
47.61%157.18M
8.22%78.81M
-11.86%29.01M
55.09%11.19M
691.71%38.18M
-Change in receivables
-4,837.51%-106.22M
-290.49%-29.1M
147.11%4.86M
-266.06%-79.91M
-110.82%-2.07M
104.64%2.24M
270.32%15.27M
41.31%-10.32M
-25.53%-21.83M
540.06%19.12M
-Change in prepaid assets
-124.16%-27.1M
-1,070.47%-11.49M
12,153.85%17.52M
-661.34%-15.58M
-90.69%-17.55M
-504.89%-12.09M
-108.22%-982K
-95.03%143K
-25.83%-2.05M
9.80%-9.21M
-Change in payables and accrued expense
616.48%99.71M
1,257.29%40.9M
177.66%34.55M
36.24%36.71M
56.32%-12.44M
-83.26%13.92M
-89.66%3.01M
-59.08%12.44M
-5.48%26.95M
-480.46%-28.48M
-Change in other current liabilities
-17.53%-25.16M
-17.35%-7.03M
-25.59%-5.52M
-19.45%-6.07M
-10.12%-6.55M
-13.43%-21.41M
-34.91%-5.99M
13.10%-4.39M
-24.03%-5.08M
-12.53%-5.95M
-Change in other working capital
-11.16%155.04M
-57.27%28.84M
15.79%36.05M
433.79%70.43M
-68.55%19.72M
99.40%174.52M
49.46%67.49M
39.83%31.13M
626.60%13.2M
242.87%62.7M
Cash from discontinued investing activities
Operating cash flow
17.15%713.22M
1.04%192.65M
65.16%246.21M
27.60%148.53M
-17.58%125.84M
40.48%608.82M
21.91%190.67M
30.33%149.08M
41.06%116.4M
90.67%152.68M
Investing cash flow
Cash flow from continuing investing activities
-10.00%-31.14M
40.85%-4.47M
-1.66%-10.66M
52.93%-6.02M
-494.74%-9.99M
18.25%-28.31M
5.44%-7.56M
-21.06%-10.49M
-51.06%-12.79M
126.62%2.53M
Capital expenditure reported
----
----
----
52.51%-6.11M
-81.81%-9.99M
----
----
----
---12.87M
---5.5M
Net PPE purchase and sale
14.21%-31.36M
40.65%-4.54M
----
----
----
0.27%-36.55M
23.46%-7.64M
----
----
----
Net other investing changes
-97.38%216K
-22.22%63K
3.92%53K
14.81%93K
-99.91%7K
308.12%8.24M
-95.93%81K
24.39%51K
485.71%81K
80,170.00%8.03M
Cash from discontinued investing activities
Investing cash flow
-10.00%-31.14M
40.85%-4.47M
-1.66%-10.66M
52.93%-6.02M
-494.74%-9.99M
18.25%-28.31M
5.44%-7.56M
-21.06%-10.49M
-51.06%-12.79M
126.62%2.53M
Financing cash flow
Cash flow from continuing financing activities
-458.66%-860.39M
113.48%22.73M
-45.60%3.41M
-81,265.77%-540.56M
-4,616.53%-345.97M
15.68%-154.01M
-11,170.85%-168.61M
112.73%6.27M
100.81%666K
114.54%7.66M
Net issuance payments of debt
--0
----
----
----
----
--0
--0
--0
----
----
Net common stock issuance
-440.06%-917.39M
--0
---4.57M
---540.92M
---371.9M
-17.95%-169.87M
---169.87M
--0
--0
--0
Proceeds from stock option exercised by employees
259.45%57M
1,706.76%22.73M
27.30%7.99M
-47.30%351K
238.56%25.93M
39.37%15.86M
-17.40%1.26M
9.53%6.27M
-59.98%666K
211.00%7.66M
Cash from discontinued financing activities
Financing cash flow
-458.66%-860.39M
113.48%22.73M
-45.60%3.41M
-81,265.77%-540.56M
-4,616.53%-345.97M
15.68%-154.01M
-11,170.85%-168.61M
112.73%6.27M
100.81%666K
114.54%7.66M
Net cash flow
Beginning cash position
172.74%669.44M
-56.56%285.35M
-90.93%46.33M
8.46%441.44M
172.74%669.44M
768.38%245.45M
589.97%656.9M
1,205.37%510.89M
767.42%407.01M
768.38%245.45M
Current changes in cash
-141.81%-178.31M
1,355.04%210.91M
64.96%238.96M
-481.75%-398.06M
-241.29%-230.12M
97.36%426.5M
-90.33%14.5M
156.62%144.86M
1,378.01%104.27M
810.38%162.87M
Effect of exchange rate changes
335.68%5.92M
140.33%790K
-94.84%59K
858.87%2.95M
262.10%2.12M
-332.28%-2.51M
-710.28%-1.96M
399.21%1.14M
-203.73%-389K
-270.27%-1.31M
End cash Position
-25.75%497.05M
-25.75%497.05M
-56.56%285.35M
-90.93%46.33M
8.46%441.44M
172.74%669.44M
172.74%669.44M
589.97%656.9M
1,205.37%510.89M
767.42%407.01M
Free cash flow
19.15%681.87M
2.78%188.12M
69.99%235.5M
37.56%142.41M
-21.29%115.84M
44.25%572.27M
25.01%183.02M
31.09%138.54M
39.76%103.53M
108.58%147.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.15%713.22M1.04%192.65M65.16%246.21M27.60%148.53M-17.58%125.84M40.48%608.82M21.91%190.67M30.33%149.08M41.06%116.4M90.67%152.68M
Net income from continuing operations 11.56%451.12M15.48%135.13M15.25%111.14M2.16%90.26M11.70%114.6M42.99%404.39M49.45%117.02M36.68%96.43M44.68%88.35M40.74%102.59M
Depreciation and amortization -3.85%28.12M-5.00%7.13M-6.24%7.05M-3.05%7.01M-0.89%6.93M11.10%29.25M7.66%7.51M9.31%7.52M10.97%7.24M17.35%6.99M
Deferred tax 403.29%80.77M171.93%17.41M1,983.09%28.51M63,261.11%34.11M186.59%749K-6.03%-26.63M-75.24%-24.2M80.08%-1.51M97.96%-54K18.63%-865K
Other non cash items 15.82%22.14M-7.14%5.24M-3.08%5.73M-7.99%5.61M279.40%5.56M-14.48%19.12M-18.77%5.65M-10.98%5.91M11.62%6.09M-55.60%1.47M
Change In working capital -38.75%96.28M-71.93%22.12M201.52%87.46M-50.03%5.59M-149.48%-18.89M47.61%157.18M8.22%78.81M-11.86%29.01M55.09%11.19M691.71%38.18M
-Change in receivables -4,837.51%-106.22M-290.49%-29.1M147.11%4.86M-266.06%-79.91M-110.82%-2.07M104.64%2.24M270.32%15.27M41.31%-10.32M-25.53%-21.83M540.06%19.12M
-Change in prepaid assets -124.16%-27.1M-1,070.47%-11.49M12,153.85%17.52M-661.34%-15.58M-90.69%-17.55M-504.89%-12.09M-108.22%-982K-95.03%143K-25.83%-2.05M9.80%-9.21M
-Change in payables and accrued expense 616.48%99.71M1,257.29%40.9M177.66%34.55M36.24%36.71M56.32%-12.44M-83.26%13.92M-89.66%3.01M-59.08%12.44M-5.48%26.95M-480.46%-28.48M
-Change in other current liabilities -17.53%-25.16M-17.35%-7.03M-25.59%-5.52M-19.45%-6.07M-10.12%-6.55M-13.43%-21.41M-34.91%-5.99M13.10%-4.39M-24.03%-5.08M-12.53%-5.95M
-Change in other working capital -11.16%155.04M-57.27%28.84M15.79%36.05M433.79%70.43M-68.55%19.72M99.40%174.52M49.46%67.49M39.83%31.13M626.60%13.2M242.87%62.7M
Cash from discontinued investing activities
Operating cash flow 17.15%713.22M1.04%192.65M65.16%246.21M27.60%148.53M-17.58%125.84M40.48%608.82M21.91%190.67M30.33%149.08M41.06%116.4M90.67%152.68M
Investing cash flow
Cash flow from continuing investing activities -10.00%-31.14M40.85%-4.47M-1.66%-10.66M52.93%-6.02M-494.74%-9.99M18.25%-28.31M5.44%-7.56M-21.06%-10.49M-51.06%-12.79M126.62%2.53M
Capital expenditure reported ------------52.51%-6.11M-81.81%-9.99M---------------12.87M---5.5M
Net PPE purchase and sale 14.21%-31.36M40.65%-4.54M------------0.27%-36.55M23.46%-7.64M------------
Net other investing changes -97.38%216K-22.22%63K3.92%53K14.81%93K-99.91%7K308.12%8.24M-95.93%81K24.39%51K485.71%81K80,170.00%8.03M
Cash from discontinued investing activities
Investing cash flow -10.00%-31.14M40.85%-4.47M-1.66%-10.66M52.93%-6.02M-494.74%-9.99M18.25%-28.31M5.44%-7.56M-21.06%-10.49M-51.06%-12.79M126.62%2.53M
Financing cash flow
Cash flow from continuing financing activities -458.66%-860.39M113.48%22.73M-45.60%3.41M-81,265.77%-540.56M-4,616.53%-345.97M15.68%-154.01M-11,170.85%-168.61M112.73%6.27M100.81%666K114.54%7.66M
Net issuance payments of debt --0------------------0--0--0--------
Net common stock issuance -440.06%-917.39M--0---4.57M---540.92M---371.9M-17.95%-169.87M---169.87M--0--0--0
Proceeds from stock option exercised by employees 259.45%57M1,706.76%22.73M27.30%7.99M-47.30%351K238.56%25.93M39.37%15.86M-17.40%1.26M9.53%6.27M-59.98%666K211.00%7.66M
Cash from discontinued financing activities
Financing cash flow -458.66%-860.39M113.48%22.73M-45.60%3.41M-81,265.77%-540.56M-4,616.53%-345.97M15.68%-154.01M-11,170.85%-168.61M112.73%6.27M100.81%666K114.54%7.66M
Net cash flow
Beginning cash position 172.74%669.44M-56.56%285.35M-90.93%46.33M8.46%441.44M172.74%669.44M768.38%245.45M589.97%656.9M1,205.37%510.89M767.42%407.01M768.38%245.45M
Current changes in cash -141.81%-178.31M1,355.04%210.91M64.96%238.96M-481.75%-398.06M-241.29%-230.12M97.36%426.5M-90.33%14.5M156.62%144.86M1,378.01%104.27M810.38%162.87M
Effect of exchange rate changes 335.68%5.92M140.33%790K-94.84%59K858.87%2.95M262.10%2.12M-332.28%-2.51M-710.28%-1.96M399.21%1.14M-203.73%-389K-270.27%-1.31M
End cash Position -25.75%497.05M-25.75%497.05M-56.56%285.35M-90.93%46.33M8.46%441.44M172.74%669.44M172.74%669.44M589.97%656.9M1,205.37%510.89M767.42%407.01M
Free cash flow 19.15%681.87M2.78%188.12M69.99%235.5M37.56%142.41M-21.29%115.84M44.25%572.27M25.01%183.02M31.09%138.54M39.76%103.53M108.58%147.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -